BIG
ABVX icon

Brooklyn Investment Group’s Abivax ABVX Stock Holding History

Brooklyn Investment Group’s Portfolio ABVX Stock Details ABVX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$344K Sell
3,088
-82
-3% -$9.7K 0.01% 1311
2025
Q4 		$445K Buy
+3,170
New +$346K 0.02% 754

Other funds holding ABVX

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
VPC
Vestal Point Capital New York $4.28B AUM 239% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HI
Helikon Investments London, United Kingdom $3.35B AUM 55.08% 1-Year Est. Return

Brooklyn Investment Group's ABVX Position: Q1 2026 in Review

Brooklyn Investment Group reduced its Abivax (ABVX) stake by 2.6% in Q1 2026, selling an estimated $9.7K and leaving 3,088 shares worth $344K. The position accounts for 0.01% of the portfolio, ranked #1311.

Brooklyn Investment Group first reported a position in ABVX in Q4 2025 and has held it in 2 quarters since. The position peaked at $445K in Q4 2025. 254 funds tracked by Wall St. Rank hold ABVX as of Q1 2026.

  • Brooklyn Investment Group held 3,088 shares of Abivax worth $344K as of Q1 2026.
  • Brooklyn Investment Group sold 82 Abivax shares in Q1 2026, an estimated $9.7K.
  • Abivax made up 0.01% of Brooklyn Investment Group's portfolio in Q1 2026, its #1311 holding.
  • Brooklyn Investment Group first reported a position in Abivax in Q4 2025 and has held it in 2 quarters since.
  • Brooklyn Investment Group's Abivax position peaked at $445K in Q4 2025.
  • 254 funds tracked by Wall St. Rank held Abivax as of Q1 2026.

Based on Brooklyn Investment Group's 13F filing for Q1 2026, filed 29 Apr 2026.